Genetic susceptibility to Tardive Dyskinesia in chronic schizophrenia subjects: role of oxidative stress pathway genes.
Thelma
B K
BK
Tiwari
Arun K
AK
Deshpande
Smita N
SN
Lerer
Bernard
B
Nimgaonkar
Vishwajit L
VL
D014150:Antipsychotic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D002908:Chronic Disease; D004409:Dyskinesia, Drug-Induced / Q000453:epidemiology* / Q000209:etiology*; D020022:Genetic Predisposition to Disease; D006239:Haplotypes / Q000235:genetics; D006801:Humans; D009434:Neural Pathways / Q000503:physiopathology*; D010084:Oxidation-Reduction / Q000187:drug effects; D018384:Oxidative Stress / Q000235:genetics*; D012559:Schizophrenia / Q000188:drug therapy / Q000453:epidemiology / Q000235:genetics
D014150:Antipsychotic Agents